At a glance
ClinicalIndex Comparison RecordN/ACompleted· 335 enrolled
Drug / intervention
Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics
In Brief
A clinical study evaluating Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter for Type 1 Diabetes Mellitus and Type2 Diabetes Mellitus. Completed, enrolled 335 participants across 15 sites.
Detailed Summary
The purpose of this study is to demonstrate the performance of the Guardian™ Sensor (3) with an advanced algorithm in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus, Type2 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartJun 2019
Primary CompletionMay 2020
TodayJul 2026
First PostedMay 29, 2019
Enrollment StartJun 14, 2019
Primary CompletionMay 13, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.1 years ago
Interventions
Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitterdevice
Continuous Glucose Monitoring and frequent sample testing